Article Image


The delivery of effective therapeutics requires new approaches to data mining and this can be riddled with challenges. Read about how PerkinElmer Signals™ Translational, an integrated solution that streamlines data integration, harmonization and analytics helped researchers at the Frederick National Laboratory for Cancer Research (FNL) - sponsored by the National Cancer Institute (NCI)- to interrogate complex data from a study designed to evaluate the therapeutic potential of combining FDA-approved oncology drugs.

Like what you're reading?

To view the full content, please fill out this form: